AMBER KINTIGH: Open Payments
NPI 1780619791 · GRANDVILLE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,601 in 77 payments from 14 companies in 2025. Trend: 2023 $1,463 · 2024 $1,572 · 2025 $1,601
Food & beverage: $1,601
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $445 |
| ABBVIE INC. | 13 | $315 |
| Incyte Corporation | 10 | $162 |
| GENZYME CORPORATION | 6 | $123 |
| PFIZER INC. | 5 | $97 |
| UCB, Inc. | 3 | $90 |
| Regeneron Healthcare Solutions, Inc. | 3 | $78 |
| Arcutis Biotherapeutics, Inc. | 3 | $61 |
| Amgen Inc. | 3 | $57 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $46 |
Products named: COSENTYX, RINVOQ, DUPIXENT, OPZELURA, SKYRIZI, EUCRISA, Bimzelx, Zoryve.
Industry payments across MI — which companies pay providers there.
